Trials / Completed
CompletedNCT00643669
24 Hour IOP Lowering Efficacy of AL-3789
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study was to describe the intraocular pressure-lowering efficacy of AL-3789 over a 24-hour period in patients with open-angle glaucoma compared to an untreated control. Patients received one treatment of AL-3789. Twenty-eight days after treatment, IOP was measured every 4 hours, beginning at 8 AM for 24 hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AL-3789 Sterile Suspension | Single administration by anterior juxtascleral depot |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2008-04-01
- First posted
- 2008-03-26
- Last updated
- 2012-11-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00643669. Inclusion in this directory is not an endorsement.